TNFSF13B and B-cell chronic lymphocytic leukemia: Even after restricting the analysis to cases diagnosed > 10 years after blood draw, BAFF remained protective for CLL (ORcontinuous = 0.40, 95% CI: 0.19–0.83, P = 0.01).